PE treatment by risk stratifications


  • increased risk of bleeding over 65
  • extensive clot and clot: less strong indication
  • guideline
  • Pytho study
  • TPA for intermediate risk: lower incidence of death or hemodynamics decompensation but higher risk of bleeding
  • no mortality benefit
  • against systemic TPA for intermediate
  • high risk PE. No difference with IVC filter in recurrence 1

Footnotes

  1. CHEST Board Review Critical Care?